The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative is currently conducting clinical trials to advance COVID-19 vaccines and therapeutics to both prevent COVID-19 and treat mild to life-threatening COVID-19 infection. The mission of ACTIV is to reduce the morbidity and mortality from COVID-19 and to accelerate the end of the SARS-CoV-2 outbreak.
ACTIV is a public-private partnership led by the National Institutes of Health (NIH), which leverages scientific innovation from across US government agencies, private pharmaceutical companies, academia, and philanthropic foundations. The Foundation for the National Institutes of Health provides logistical and management support to ACTIV
COMMENTARY
The ACTIV COVID-19 Clinical Trials: 5 Things to Know
Elizabeth Higgs, MD, DTMH, MIA
DisclosuresNovember 12, 2021
Editorial Collaboration
Medscape &
The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative is currently conducting clinical trials to advance COVID-19 vaccines and therapeutics to both prevent COVID-19 and treat mild to life-threatening COVID-19 infection. The mission of ACTIV is to reduce the morbidity and mortality from COVID-19 and to accelerate the end of the SARS-CoV-2 outbreak.
ACTIV is a public-private partnership led by the National Institutes of Health (NIH), which leverages scientific innovation from across US government agencies, private pharmaceutical companies, academia, and philanthropic foundations. The Foundation for the National Institutes of Health provides logistical and management support to ACTIV
Join the Top Medical Resource for Physicians Today. Free Membership!
Credits:
Lead image: Getty Images
Image 1: Centers for Disease Control and Prevention
Public Information from the CDC and Medscape
Cite this: The ACTIV COVID-19 Clinical Trials: 5 Things to Know - Medscape - Nov 12, 2021.
Tables
Authors and Disclosures
Authors and Disclosures
Author
Elizabeth Higgs, MD, DTMH, MIA
Global Health Science Advisor, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services
Disclosure: Elizabeth Higgs, MD, DTMH, MIA, has disclosed no relevant financial relationships.